Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer.

Tan, E H; Rolski, J; Grodzki, T; Schneider, C P; Gatzemeier, U; Zatloukal, P; Aitini, E; Carteni, G; Riska, H; Tsai, Y H; Abratt, R

Tan, E H; Rolski, J; Grodzki, T; Schneider, C P; Gatzemeier, U; Zatloukal, P; Aitini, E; Carteni, G; Riska, H; Tsai, Y H; Abratt, R.

Affiliation

Tan EH; Department of Medical Oncology, Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore. tanenghuat123@gmail.com

Ann Oncol ; 20(7): 1249-56, 2009 Jul.

Article in En | MEDLINE | ID: mdl-19276396

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Non-Small-Cell Lung/drug therapy; Lung Neoplasms/drug therapy; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cisplatin/administration & dosage; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Prospective Studies; Quality of Life; Survival Analysis; Taxoids/administration & dosage; Treatment Outcome; Vinblastine/administration & dosage; Vinblastine/analogs & derivatives; Vinorelbine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Ann Oncol Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google